Grund Nicholas - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 31, 2024, Grund Nicholas's relationship to Akebia Therapeutics, Inc. (AKBA) is Officer (Chief Commercial Officer), and currently has 303,300 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKBA insiders.

Data Source: SEC.
Grund Nicholas - Insider Non-Derivative Transactions of AKBA Common Stock
Grund Nicholas - Insider Non-Derivative Transactions at AKBA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 1, 2024 Acquisition -- (Common Stock) 303300 0 303300